NLRP2, an inhibitor of the NF-κB pathway, is transcriptionally activated by NF-κB and exhibits a nonfunctional allelic variant

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8519-8524

  Fontalba, Ana ^a   Gutierrez, Olga ^a   Fernandez Luna, Jose L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NLRP2 PROTEIN; NUCLEIC ACID BINDING PROTEIN; NUCLEOTIDE; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NLRP2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR RELA;

ADIPOCYTE; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN HEK293; CHRONIC INFLAMMATION; CONTROLLED STUDY; DNA BINDING; FEVER; GENE AMPLIFICATION; GENE SEQUENCE; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; ALLELE; AMINO ACID SEQUENCE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; MOLECULAR GENETICS; TRANSACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELES; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL LINE; GENE FREQUENCY; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 40049089542     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8519     Document Type: Article

References (38)

1. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κ B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
2. Smahi, A., G. Courtois, S. H. Rabia, R. Doffinger, C. Bodemer, A. Munnich, J. L. Casanova, and A. Israel. 2002. The NF-κB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet. 11: 2371-2375.
3. Harton, J. A., M. W. Linhoff, J. Zhang, and J. P. Ting. 2002. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 169: 4088-4093.
4. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276: 4812-4818.
5. Ting, J. P., D. L. Kastner, and H. M. Hoffman. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6: 183-195.
6. Bruey, J. M., N. Bruey-Sedano, R. Newman, S. Chandler, C. Stehlik, and J. C. Reed. 2004. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages. J. Biol. Chem. 279: 51897-51907.
7. O'Connor, W., Jr., J. A. Harton, X. Zhu, M. W. Linhoff, and J. P. Ting. 2003. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-κB suppressive properties. J. Immunol. 171: 6329-6333.
8. Fiorentino, L., C. Stehlik, V. Oliveira, M. E. Ariza, A. Godzik, and J. C. Reed. 2002. A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 277: 35333-35340.
9. Wang, Y., M. Hasegawa, R. Imamura, T. Kinoshita, C. Kondo, K. Konaka, and T. Suda. 2004. PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1. Int. Immunol. 16: 777-786.
10. Kobayashi, K., N. Inohara, L. Hernandez, J. Galan, G. Nunez, C. Janeway, R. Medzhitov, and R. Flavell. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199.
11. Hoffman, H. M., J. L. Mueller, D. H. Broide, A. A. Wanderer, and R. D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29: 301-305.
12. Agostini, L., F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins, and J. Tschopp. 2004. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325.
13. Ogura, Y., D. Bonen, N. Inohara, D. Nicolae, F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
14. Gutierrez, O., C. Pipaon, N. Inohara, A. Fontalba, Y. Ogura, F. Prosper, G. Nunez, and J. L. Fernandez-Luna. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J. Biol. Chem. 277: 41701-41705.
15. Kinoshita, T., Y. Wang, M. Hasegawa, R. Imamura, and T. Suda. 2005. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1β secretion. J. Biol. Chem. 280: 21720-21725.
16. Sanz, C., A. Benito, M. Silva, B. Albella, C. Richard, J. C. Segovia, A. Insunza, J. A. Bueren, and J. L. Fernandez-Luna. 1997. The expression of Bcl-x is down-regulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood 89: 3199-3204.
17. Real, P. J., A. Sierra, A. De Juan, J. C. Segovia, J. M. Lopez-Vega, and J. L. Fernandez-Luna. 2002. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21: 7611-7618.
18. Real, P. J., C. Sanz, O. Gutierrez, C. Pipaon, A. M. Zubiaga, and J. L. Fernandez-Luna. 2006. Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells. FEBS Lett. 580: 5905-5909.
19. Inohara, N., Y. Ogura, F. F. Chen, A. Muto, and G. Nunez. 2001. Human nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-2554.
20. May, M., and S. Ghosh. 1998. Signal transduction through NF-κB. Immunol. Today 19: 80-88.
21. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915.
22. Sampath, D., M. Castro, D. C. Look, and M. J. Holtzman. 1999. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J. Clin. Invest. 103: 1353-1361.
23. Karsunky, H., H. Zeng, T. Schmidt, B. Zevnik, R. Kluge, K. W. Schmid, U. Duhrsen, and T. Moroy. 2002. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat. Genet. 30: 295-300.
24. Tschopp, J., F. Martinon, and K. Burns. 2003. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4: 95-104.
25. Albrecht, M., F. S. Domingues, S. Schreiber, and T. Lengauer. 2003. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett. 554: 520-528.
26. Ruocco, M. G., S. Maeda, J. M. Park, T. Lawrence, L. C. Hsu, Y. Cao, G. Schett, E. F. Wagner, and M. Karin. 2005. IκB kinase (IKK) β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201: 1677-1687.
27. Giron-Michel, J., A. Caignard, M. Fogli, D. Brouty-Boye, D. Briard, M. van Dijk, R. Meazza, S. Ferrini, C. Lebousse-Kerdiles, D. Clay, et al. 2003. Differential STAT3, STAT5, and NF-κB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood 102: 109-117.
28. Sitcheran, R., P. C. Cogswell, and A. S. Baldwin, Jr. 2003. NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 17: 2368-2373.
29. Giri, R. K., S. K. Selvaraj, and V. K. Kalra. 2003. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J. Immunol. 170: 5281-5294.
30. Chen, Y., and R. W. Currie. 2005. Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflamm. Res. 54: 338-343.
31. Shuto, T., A. Imasato, H. Jono, A. Sakai, H. Xu, T. Watanabe, D. Rixter, H. Kai, A. Andalibi, F. Linthicum, et al. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277: 17263-17270.
32. Cavanaugh, J. 2006. NOD2: ethnic and geographic differences. World J. Gastroenterol. 12: 3673-3677.
33. Aganna, E., F. Martinon, P. N. Hawkins, J. B. Ross, D. C. Swan, D. R. Booth, H. J. Lachmann, A. Bybee, R. Gaudet, P. Woo, et al. 2002. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46: 2445-2452.
34. Lesage, S., H. Zouali, J. P. Cezard, J. F. Colombel, J. Belaiche, S. Almer, C. Tysk, C. O'Morain, M. Gassull, V. Binder, et al. 2002. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70: 845-857.
35. Courtois, G., and T. D. Gilmore. 2006. Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25: 6831-6843.
36. McGovern, D. P., H. Butler, T. Ahmad, M. Paolucci, D. A. van Heel, K. Negoro, P. Hysi, J. Ragoussis, S. P. Travis, L. R. Cardon, and D. P. Jewell. 2006. TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 131: 1190-1196.
37. Zhang, X., A. Shaw, P. A. Bates, R. H. Newman, B. Gowen, E. Orlova, M. A. Gorman, H. Kondo, P. Dokurno, J. Lally, et al. 2000. Structure of the AAA ATPase p97. Mol. Cell. 6: 1473-1484.
38. Chamaillard, M., D. Philpott, S. E. Girardin, H. Zouali, S. Lesage, F. Chareyre, T. H. Bui, M. Giovannini, U. Zaehringer, V. Penard-Lacronique, et al. 2003. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. USA 100: 3455-3460.